Virtual West Oncology Conference


 

2021 Update on ADT Intensification for mCSPC: What Are the Benefits & Survival Rates of Apalutamide? When It Should Be Administered for Better Outcomes?

49 views
March 5, 2021
0 Comments
Login to view comments. Click here to Login